Hardly. If they have, then they have just moved off the starting block.
It was reported here earlier that they are only just applying for an IND from the FDA and are hoping to commence phase 1 trials in the third quarter of 2020 still a long way to go.
It also seems to work as a quasi-vaccine (antibodies injections etc), but there is doubts around it being able to last for long periods of time and whether there is enough plasma in order to meet demand. The company is also very small so not sure what their production capabilities are.
Seems they are two very different companies doing very different things.
Hardly. If they have, then they have just moved off the starting...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $1.133M | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 151980 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.0¢ | 29989 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |